Copper News and Research

RSS

No serious health risk for commuters on London's Underground

Commuters and workers on the London’s Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.

17 May 2005

Research may re-define management of heart failure in diabetes

Control of oxidised copper levels in the body may be as important as lowering blood glucose levels in preventing cardiovascular complications in diabetes mellitus, according to New Zealand researchers.

28 Apr 2005

Legionnaire's disease confirmed at New York hospital

A New York hospital has confirmed that an autopsy on one of the patients who died while being treated for suspected Legionnaire's disease did have the disease. The New York-Presbyterian Hospital/Columbia University Medical Center say they are taking the matter very seriously and are implementing all necessary measures to insure the safety of patients.

26 Apr 2005

An exceptionally effective lead-detection protein

Scientists from the U.S. Department of Energy’s Brookhaven National Laboratory and the University of Chicago have discovered that a member of a well-known protein family is better at detecting lead than any other known substance.

5 Apr 2005

Increases in macronutrient consumption during pregnancy can lead to increased birthweight

Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.

3 Mar 2005

World’s strongest acid may have a role in synthesizing pharmaceuticals

Researchers at the University of California, Riverside have discovered the world’s strongest acid. Remarkably it is also the gentlest acid. This non-toxic and non-corrosive acid may have a role in processes such as improving the quality of gasoline, developing polymers and synthesizing pharmaceuticals.

16 Nov 2004

New clues about how brain cells are damaged by Alzheimer's disease

University of Kentucky chemistry professor Allan Butterfield has uncovered new clues about how brain cells are damaged by Alzheimer's disease, evidence suggesting vitamin E may help prevent the debilitating illness.

1 Nov 2004

Red-headed women are enjoying a new status as sex symbols

Ms Third, a natural red head, said flame-haired women have begun to surpass the stereotypical Aussie icon of the blonde hair, blue-eyed beach bunny in the sex appeal stakes.

8 Sep 2004

Kiwis reverse heart disease in diabetics

New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

30 Aug 2004

Overcoming the problems associated with adding omega-3s to food

As the health benefits of omega-3 fatty acids reach the awareness of consumers eager to improve the functions of their body -- from the cardiovascular system to the brain -- food makers are scurrying to enrich and fortify products with omega-3s and get them to market. But one major obstacle tempers progress -- flavor.

26 Jul 2004

MRSA contamination can be reduced by using copper alloys for surfaces in healthcare facilities

Methicillin resistant Staphylococcus aureus (MRSA) is a virulent organism, essentially resistant to all beta-lactam antibiotics (for example: penicillins, ampicillins, cephalosporins). It can cause skin, bone and life-threatening blood infections, as well as pneumonia.

7 Jul 2004

New study to determine the effectiveness of a new pediatric screening method for Wilson's disease

Mayo Clinic seeks normal healthy children and young adults between the ages of 3 months and 18 years for a research study to determine the effectiveness of a new pediatric screening method for Wilson's disease.

7 Jun 2004

San Diego seawater contains neurotoxin that can poison human consumers of shellfish

Researchers at Scripps Institution of Oceanography at the University of California, San Diego, have documented for the first time in San Diego seawater the presence of a neurotoxin that has been known to poison marine mammals, birds and human consumers of shellfish.

12 Apr 2004

First large-scale clinical trial of chelation therapy, a controversial treatment for heart disease

NYU Medical Center has begun enrolling patients in the first large-scale clinical trial of chelation therapy, a controversial treatment for heart disease widely practiced by complementary and alternative medicine physicians. The new, government-funded nationwide study will determine whether the therapy benefits people with coronary artery disease, the leading cause of death for both men and women in the United States.

30 Mar 2004